Literature DB >> 27482832

Procedures for Analysis of Dried Plasma Using Microsampling Devices to Detect Sulfur Mustard-Albumin Adducts for Verification of Poisoning.

Harald John1, Sophia Willoh2, Philipp Hörmann3, Markus Siegert4, Antje Vondran2, Horst Thiermann1.   

Abstract

Incorporation of the chemical warfare agent sulfur mustard (SM) produces a covalent adduct with human serum albumin (HSA) representing an established plasma biomarker of poisoning. Bioanalytical verification requires both plasma generation from whole blood and shipping to specialized laboratories following strict guidelines for complex packaging. These needs often push the infrastructural boundary in crisis regions and war zones. Therefore, we herein originally introduce different reliable bioanalytical procedures using filter paper as well as novel volumetric microsampling tools (Mitra devices and Noviplex DUO cards) to generate dried plasma samples not liable to the shipping constraints. In addition, the Noviplex device enables in-transit separation of plasma from whole blood without the need of a centrifuge. Plasma-loaded and dried devices were subjected to pronase treatment yielding the alkylated dipeptide hydroxyethylthioethyl-CysPro (HETE-CP) derived from the HSA-SM adduct that was detected by microbore liquid chromatography-electrospray ionization tandem-mass spectrometry (μLC-ESI MS/MS). For all devices, samples exposed to SM yielded excellent linearity (0.025-50 μM SM) and good precision (≤13%) and fulfilled forensic quality criteria for ion ratios of qualifying and quantifying product ions. Stability of the HSA-SM adduct in dried and liquid plasma is shown under conditions of three climatic zones (temperate climate, hot and dry climate, and hot and humid climate) for at least 9 days simulating the period of delayed sample shipping. Our results originally document that dried plasma is appropriate for storage and shipping at ambient temperature and that novel microsampling tools are of essential benefit when targeting the HSA-SM adduct for verification analysis.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27482832     DOI: 10.1021/acs.analchem.6b02199

Source DB:  PubMed          Journal:  Anal Chem        ISSN: 0003-2700            Impact factor:   6.986


  6 in total

1.  A quantitative method to detect human exposure to sulfur and nitrogen mustards via protein adducts.

Authors:  Brooke G Pantazides; Jennifer Quiñones-González; Danisha M Rivera Nazario; Brian S Crow; Jonas W Perez; Thomas A Blake; Rudolph C Johnson
Journal:  J Chromatogr B Analyt Technol Biomed Life Sci       Date:  2019-05-05       Impact factor: 3.205

2.  A proteomics strategy for the identification of multiple sites in sulfur mustard-modified HSA and screening potential biomarkers for retrospective analysis of exposed human plasma.

Authors:  Bo Chen; Qiaoli Zhang; Zhe Ren; Tao Zhang; Huilan Yu; Changcai Liu; Yang Yang; Ping Xu; Shilei Liu
Journal:  Anal Bioanal Chem       Date:  2022-04-27       Impact factor: 4.142

3.  Highly stable peptide adducts from hard keratins as biomarkers to verify local sulfur mustard exposure of hair by high-resolution mass spectrometry.

Authors:  Wolfgang Schmeißer; Markus Siegert; Horst Thiermann; Theo Rein; Harald John
Journal:  Arch Toxicol       Date:  2022-05-16       Impact factor: 6.168

4.  Adduct of the blistering warfare agent sesquimustard with human serum albumin and its mass spectrometric identification for biomedical verification of exposure.

Authors:  Marc-Michael Blum; Annika Richter; Markus Siegert; Horst Thiermann; Harald John
Journal:  Anal Bioanal Chem       Date:  2020-09-09       Impact factor: 4.142

Review 5.  Volumetric Absorptive Microsampling as a Sampling Alternative in Clinical Trials and Therapeutic Drug Monitoring During the COVID-19 Pandemic: A Review.

Authors:  Yahdiana Harahap; Rasmina Diptasaadya; Denni Joko Purwanto
Journal:  Drug Des Devel Ther       Date:  2020-12-31       Impact factor: 4.162

6.  Dried Plasma Spot Based LC-MS/MS Method for Monitoring of Meropenem in the Blood of Treated Patients.

Authors:  Haiwei Cao; Yi Jiang; Shaomin Wang; Haihuan Cao; Yanyan Li; Jing Huang
Journal:  Molecules       Date:  2022-03-19       Impact factor: 4.411

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.